NOVELTY - Non-naturally occurring microbial organism having a malonyl-coenzyme A (CoA) independent fatty acyl-CoA elongation (MI-FAE) cycle and/or a malonyl-CoA dependent fatty acyl-CoA elongation (MD-FAE) cycle in combination with a termination pathway, is new.    USE - The non-naturally occurring microbial organism is useful for producing (I), which is useful for producing a biobased product including a biofuel, chemical, polymer, surfactant, soap, detergent, shampoo, lubricating oil additive, fragrance, flavor material or acrylate, where the polymer is useful for preparing a molded product (all claimed).    ADVANTAGE - The non-naturally occurring microbial organism produces (I) with increased yield.    DETAILED DESCRIPTION - Non-naturally occurring microbial organism having a malonyl-coenzyme A (CoA) independent fatty acyl-CoA elongation (MI-FAE) cycle and/or a malonyl-CoA dependent fatty acyl-CoA elongation (MD-FAE) cycle in combination with a termination pathway, is new. The MI-FAE cycle comprises one or more thiolase, one or more 3-oxoacyl-CoA reductase, one or more 3-hydroxyacyl-CoA dehydratase, and one or more enoyl-CoA reductase. The MD-FAE cycle comprises one or more elongase, one or more 3-oxoacyl-CoA reductase, one or more 3-hydroxyacyl-CoA dehydratase, and one or more enoyl-CoA reductase. The termination pathway comprises a pathway comprising (A1) 1H, (A2) 1K and 1L, (A3) 1E and 1N, (A4) 1K, 1J, and 1N, (A5) 1E, (A6) 1K and 1J, (A7) 1H and 1N, (A8) 1K, 1L, and 1N, (A9) 1E and 1F, (A10) 1K, 1J, and 1F, (A11) 1H, 1N, and 1F, (A12) 1K, 1L, 1N, and 1F, or (A13) 1G. 1E is an acyl-CoA reductase (aldehyde forming). 1F is an alcohol dehydrogenase. 1G is an acyl-CoA reductase (alcohol forming). 1H is an acyl-CoA hydrolase, acyl-CoA transferase or acyl-CoA synthase. 1J is an acyl-acyl-carrier-protein (ACP) reductase. 1K is an acyl-CoA:ACP acyltransferase. 1L is a thioesterase. 1N is an aldehyde dehydrogenase (acid forming) or a carboxylic acid reductase. An enzyme of the MI-FAE cycle, MD-FAE cycle or termination pathway is encoded by at least one exogenous nucleic acid and is expressed in a sufficient amount to produce a fatty alcohol/fatty aldehyde/fatty acid compound of formula (I). The substrate of each of the enzymes of the MI-FAE cycle, MD-FAE cycle and the termination pathway are a carbonyl compound of formula (II), malonyl-CoA, propionyl-CoA or acetyl-CoA. The enzymes of the MI-FAE cycle, the MD-FAE cycle, and the termination pathway are each selective for (II) having a number of carbon atoms at R1 i.e. no greater than the number of carbon atoms at R1 of (I).    R1 = 1-24C linear alkyl;    R2 = CH2OH, CHO, or COOH;    R3 = H, OH, or =O;    dotted line = optional bond, provided that the valency of the carbon atom to which R3 is attached is four; and    R4 = S-CoA, ACP, OH or H.    INDEPENDENT CLAIMS are included for:    (1) producing (I), comprising culturing the non-naturally occurring microbial organism under conditions and for a sufficient period of time to produce (I);    (2) culture medium comprising bioderived compound (I), where (I) has a carbon-12, carbon-13 or carbon-14 isotope ratio that reflects an atmospheric carbon dioxide uptake source;    (3) a bioderived compound (I) prepared by the method;    (4) a composition comprising either (I) and a compound other than (I), or (I) or its cell lysate or culture supernatant;    (5) a biobased product comprising (I);    (6) a molded product obtained by molding the biobased product, where the biobased product is a polymer; and    (7) producing a biobased product comprising chemically reacting (I) with itself or another compound in a reaction that produces the biobased product.